Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(coagulation)
176,877 results
  • Hazardous Wastes Treatment Technologies. [Journal Article]
    Water Environ Res 2019Wang J, Shih Y, … Huang CP
  • This is a review of the literature published in 2018 on topics related to hazardous waste management in water, soils, sediments, and air. The review covers treatment technologies applying physical, chemical, and biological principles for contaminated water, soils, sediments and air. This article is protected by copyright. All rights reserved.
  • Smart Nanotherapeutic Targeting of Tumor Vasculature. [Journal Article]
    Acc Chem Res 2019Li Z, Di C, … Nie G
  • The past decades have witnessed the development of a field dedicated to targeting tumor vasculature for cancer therapy. In contrast to conventional chemotherapeutics that need to penetrate into tumor tissues for killing tumor cells, the agents targeting tumor vascular system have two major advantages: direct contact with vascular endothelial cells or the blood and less possibility to induce drug …
  • Emerging chitin nanogels/rectorite nanocomposites for safe and effective hemorrhage control. [Journal Article]
    J Mater Chem B 2019; 7(33):5096-5103Zhang J, Xue S, … Ye Q
  • Excessive bleeding due to trauma, surgery and diseases may cause severe mortalities. Here, an emerging chitin nanogel/rectorite nanocomposite is developed for effective hemorrhage control. Chitin chains are intercalated into rectorite and subsequent mechanical high speed stirring generates chitin nanogels, which assemble on the surface of the rectorite nanoplates through electrostatic interaction…
  • Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit. [Journal Article]
    Intensive Care Med Exp 2019; 7(1):51Ki KK, Passmore MR, … Suen JY
  • CONCLUSIONS: In an ex-vivo model of ECMO, low-flow rate (1.5 L/min) altered haemostatic parameters compared to high-flow (4 L/min). Observed differences in haemolysis, ristocetin-induced platelet aggregation, high-molecular-weight vWF multimers and clot formation time suggest an increased risk of bleeding complications. Since patients are often on ECMO for protracted periods, extended-duration studies are required to characterise long-term ECMO-induced haemostatic changes.
New Search Next